In a nutshell This study looked at how medications similar to the GLP-1 hormone affect heart health for patients with type 2 diabetes (T2D). It found that GLP-1-like medications did not significantly improve heart health, but reduced overall mortality. Some background T2D is a disorder in which the body does not respond well to the hormone insulin....
Read MoreNon-insulin injected drug(s)-Byetta, (Exenatide) Posts on Medivizor
The cost effectiveness of semaglutide compared to exenatide and dulaglutide in type 2 diabetes
In a nutshell The aim of this study was to compare the cost-effectiveness of semaglutide (Ozempic) to extended-release (ER) exenatide (Byetta, Bydureon) and dulaglutide (Trulicity) ?in the treatment of type 2 diabetes (T2D). The main finding of the study was that once-weekly semaglutide was more cost-effective than exenatide and...
Read MoreEffect of long-acting exenatide on blood sugar, body weight and blood vessels in type 2 diabetes
In a nutshell The aim of this study was to examine the effect of long-acting exenatide on blood sugar control, body weight and the thickness of the wall of the carotid artery in patients with type 2 diabetes (T2D). The main finding of the study was that this treatment improved all these parameters in patients with T2D. Some background Patients withT2D...
Read More